Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Other financing activities (2018 - 2025)

Neuronetics (STIM) has disclosed Other financing activities for 7 consecutive years, with $88000.0 as the latest value for Q4 2025.

  • Quarterly Other financing activities fell 79.82% to $88000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $168000.0 through Dec 2025, down 77.27% year-over-year, with the annual reading at $168000.0 for FY2025, 93.6% down from the prior year.
  • Other financing activities for Q4 2025 was $88000.0 at Neuronetics, up from -$1.7 million in the prior quarter.
  • The five-year high for Other financing activities was $1.7 million in Q1 2025, with the low at -$1.7 million in Q3 2025.
  • Average Other financing activities over 5 years is $200000.0, with a median of $88000.0 recorded in 2025.
  • The sharpest move saw Other financing activities tumbled 85.79% in 2022, then skyrocketed 24000.0% in 2023.
  • Over 5 years, Other financing activities stood at $401000.0 in 2021, then crashed by 99.75% to $1000.0 in 2022, then surged by 24000.0% to $241000.0 in 2023, then skyrocketed by 80.91% to $436000.0 in 2024, then tumbled by 79.82% to $88000.0 in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $88000.0, -$1.7 million, and $1.7 million for Q4 2025, Q3 2025, and Q1 2025 respectively.